In-depth analysis of Asia-Pacific drug development landscape

As drug makers around the world continue to navigate the complex and ever-changing landscape referred to as the New Health, many companies are flocking to Asia-Pacific for better access to patients, improved operational efficiencies and increasingly, pharmaceutical innovation.

In a new report released today, Ferzaan Engineer, Ph.D., Chief Executive Officer of Quintiles India and Anand Tharmaratnam, M.D., Senior Vice President and Head of Clinical Development for Quintiles Asia-Pacific, provide an in-depth analysis of the Asia-Pacific drug development landscape and its evolution from outsourcing destination to potential pharmaceutical innovation hub of the future.

The report, “Realizing the Promise of Asia-Pacific,” explores the history, growth and opportunities of the Asia-Pacific region as part of the larger biopharmaceutical drug development industry. Drs. Engineer and Tharmaratnam examine the region’s ongoing transformation and explore some of the key initiatives, characteristics and advantages that they believe will be integral to the overall success of the region in the New Health landscape.

In addition, Engineer and Tharmaratnam provide their perspective on what countries in this emerging region must do in order to realize the full extent of their potential. From advancements in intellectual property protection (IPP), to harmonization of regulatory guidelines to education and disease focus, this report provides unique perspective from two regional industry leaders on the front lines of drug development in Asia-Pacific.

The full report is available for download at www.quintiles.com/perspectives/.

Dr. Tharmaratnam will be providing additional insight on many of the topics outlined in this paper during his keynote presentation at the World Pharma Trials Asia 2010 conference taking place this week at Raffles City Convention Centre in Singapore. Tharmaratnam’s presentation will begin at 9:05 a.m. on Thursday, March 18.

Source:

 Quintiles

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Quintiles. (2019, June 19). In-depth analysis of Asia-Pacific drug development landscape. News-Medical. Retrieved on January 26, 2021 from https://www.news-medical.net/news/20100317/In-depth-analysis-of-Asia-Pacific-drug-development-landscape.aspx.

  • MLA

    Quintiles. "In-depth analysis of Asia-Pacific drug development landscape". News-Medical. 26 January 2021. <https://www.news-medical.net/news/20100317/In-depth-analysis-of-Asia-Pacific-drug-development-landscape.aspx>.

  • Chicago

    Quintiles. "In-depth analysis of Asia-Pacific drug development landscape". News-Medical. https://www.news-medical.net/news/20100317/In-depth-analysis-of-Asia-Pacific-drug-development-landscape.aspx. (accessed January 26, 2021).

  • Harvard

    Quintiles. 2019. In-depth analysis of Asia-Pacific drug development landscape. News-Medical, viewed 26 January 2021, https://www.news-medical.net/news/20100317/In-depth-analysis-of-Asia-Pacific-drug-development-landscape.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Quintiles acquires premier provider of genomics testing and analysis